Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA

4 abstracts

Abstract
CYCLONE 2: A phase 3 study of abemaciclib with abiraterone in patients with metastatic castration-resistant prostate cancer.
Org: Massachusetts General Hospital Cancer Center and Harvard Medical School, Institut Català d’Oncologia–Bellvitge Institute for Biomedical Research, Studienpraxis Urologie, Asan Medical Center, Hospital Universitario Gregorio Marañón,
Abstract
AI-enabled analysis of H&E-stained prostate cancer tissue images: Assessing risk for metastasis prior to apalutamide (APA) treatment of patients with non-metastatic castration-resistant prostate cancer (nmCRPC).
Org: Janssen Research & Development, Cambridge, MA, Janssen Research & Development, Spring House, PA, Janssen Research & Development, Titusville, NJ, Janssen Research & Development, Los Angeles, CA, Janssen Research & Development, Raritan, NJ,
Abstract
Prostate-specific membrane antigen ligand positron emission tomography (PSMA-PET) disease extent and overall survival (OS) in patients (pts) with high-risk nonmetastatic castration-resistant prostate cancer (nmCRPC): An international multicenter retrospective study.
Org: University of Duisburg-Essen and German Cancer Consortium (DKTK)–University Hospital Essen, Essen, Germany, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany, Peter MacCallum Cancer Centre, Melbourne, Australia, UCLA Department of Nuclear Medicine, Los Angeles, CA, University of California Los Angeles, Los Angeles, CA,
Abstract
Efficacy and safety of darolutamide in Chinese patients with metastatic hormone-sensitive prostate cancer (mHSPC): A subpopulation analysis of the phase 3 ARASENS study.
Org: Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA, Division of Urology, IREC, Cliniques Universitaires Saint Luc, UCLouvain, Brussels, Belgium, Northwestern University, Feinberg School of Medicine, Chicago, IL, Bayer Healthcare Company Ltd., Beijing, China, Bayer Healthcare Co Ltd, Beijing, China,